This intense pulsed light (IPL) system emits highly controlled light energy into areas of skin imperfection. Once the light is absorbed by the skin, heat is generated to destroy melanin, which is a black to brown pigment responsible for hyperpigmentation of skin. To remove unsightly vascular lesions such as spider veins and telangiectasia, MaxG™ uniformly heats the entire blood vessel, causing it to shrink. Over time, the damaged abnormal blood vessel is naturally eliminated by the immune cells of the body, leading to even skin tone and fresher, rejuvenated skin.
MaxG™ IPL laser treatments will elicit a definite reduction in sun damage and clearer complexion in about two weeks after each treatment. Over the course of one to three months post-treatment, skin will continue to rejuvenate.
The MaxG™ is the best IPL in its class for several reasons. It delivers visible results quickly and is a powerful, effective treatment alternative to microdermabrasion and chemical peels. Treatment sessions take approximately 30 minutes, with little to no downtime, allowing you to quickly return to your daily activities. Traditional lasers operate on a single wavelength, while the MaxG™ employs a unique combination of Dynamic Spectrum ShiftingSM and dual-band filters for unparalleled precision and efficiency. This allows for thorough heating across the entirety of the blood vessel, providing treatment for the skin’s deepest facial vessels and the most effective outcomes.
The MaxG™ system can be safely used on individuals with Type 1 (ivory), Type 2 (Fair), Type 3 (Fair to Beige), and Type 4 (light brown) skin tones.
IPL laser treatments work by heating up the surrounding tissue and melanin in the treatment area. Dark skin types have increased melanin and, due to the heat produced, can stimulate and increase the appearance of the darkened pigmentation, making this skin type not a candidate for IPL.
It is also not recommended for individuals who have had recent sunburns, are pregnant, have a history of seizures, have severe dermatitis or eczema (within the treatment area), have active skin infections, or have used Accutane within the previous six months.
